NewslettersCell Therapy NewsLILRB1-Directed CAR-T Cells for the Treatment of Hematological MalignanciesBy Noshin Noorjahan - April 7, 202501512Researchers observed stable LILRB1 expression in B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma, even after CD20/CD19-based immunotherapies.[Leukemia]Full Article